Beta Drugs IPO

Beta Drugs IPOBusiness description from prospectus – Beta Drugs is primarily engaged in the manufacturing of oncology products. Its products range from anticancer tablets, capsules, injections and lyophilized injections. The company started production of oncology products by manufacturing portfolio of over 35 products which is used for the treatment of various cancer disease. As on March 31, 2017, the company had a portfolio of over 50 products products catering to various oncology diseases including breast, brain, bone, lung, mouth, head & neck, prostate, haematology, cervics, oeaophagus etc. It has increased its product range, starting from 35 in 2015-16 to 50 active products in 2016-17. The company’s oncology portfolio includes key brands like Admine, Adgef, Addplatin, Erlotad etc.

Promoters of Beta Drugs – Vijay Kumar Batra

Beta Drugs IPO details

Subscription Dates29 Sep - 4 Oct 2017
IPO Price bandINR85 per share
Fresh issue 2,296,000 shares (INR19.52 crore)
Offer for sale Nil
Total IPO size2,296,000 shares (INR19.52 crore)
Minimum bid (lot size)1,600 shares
Face Value INR10 per share
Retail Allocation50%
Listing OnNSE Emerge SME platform
Beta Drugs' financial performance (in INR lakh)
FY2013FY2014FY2015FY2016FY2017
Total revenue313.0138.426.22,639.54,168.2
Total expenses308.6136.237.72,526.13,650.2
Profit after tax4.42.211.4113.4517.9

Beta Drugs Limited
Village Nandpur
Baddi
Himachal Pradesh-17410

Phone: +91 01795 236196
Email: [email protected]
Website: www.betadrugslimited.com

Day

Subscription (no. of times)

Day 10.08
Day 20.66
Day 317.87

 

Earnings Per Share (EPS): INR8.69

Price/Earnings (P/E) ratio: 9.78

Return on Net Worth (RONW): 70.18%

Net Asset Value (NAV): INR12.39 per share

Link Intime India Private Limited
C-101, 247 Park, L.B.S. Marg,
Vikhroli (West), Mumbai – 400 083
Maharashtra, India

Phone: +91 22 4918 6200
Fax: +91 22 4918 6195
Email[email protected]
Website: http://www.linkintime.co.in

Beta Drugs IPO allotment status is now available on Link Intime’s website. Click on this link to get allotment status.

IPO Opening Date: 29 September 2017

IPO Closing Date: 4 October 2017

Finalisation of Basis of Allotment: 9 October 2017

Initiation of refunds: 10 October 2017

Transfer of shares to demat accounts: 11 October 2017

Listing Date: 12 October 2017

Listing Price on NSE SME: INR102 per share (up 20% from IPO price)

Closing Price on NSE SME: INR101.95 per share (up 19.94% from IPO price)

6 thoughts on “Beta Drugs IPO

  • October 11, 2017 at 4:46 PM
    Permalink

    Guys buy this share as soon as it lists….It’s going to be a multibagger stock. Mark my words.

    Reply
  • October 10, 2017 at 11:34 PM
    Permalink

    I got allocation. Sunil. Palod Gmail

    Reply
  • October 4, 2017 at 5:29 PM
    Permalink

    apply with full force and sell me ur application on confirm allotment
    i can buy all the applications u have
    8863805714
    raju

    Reply
  • October 2, 2017 at 12:47 PM
    Permalink

    What is the gmp for beta drugs?

    Reply

Leave a Reply

Your email address will not be published. Required fields are marked *